Related Experiment Video

Updated: Aug 21, 2026

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning
09:27

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning

Published on: March 15, 2011

Gene expression microarray technologies in the development of new therapeutic agents

Paul A Clarke1, Robert te Poele, Paul Workman

  • 1Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK.

European Journal of Cancer (Oxford, England : 1990)
|November 16, 2004
PubMed

Insights

Gene expression microarray technology aids cancer therapeutic discovery and development. This gene profiling helps classify cancer, identify targets, and predict drug responses, improving patient selection and treatment outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Gene expression microarray technology offers a global view of cellular activity.
  • Understanding gene expression is crucial for advancing cancer therapeutics.

Purpose of the Study:

  • To review the multifaceted benefits of gene expression microarray technology in cancer drug discovery and development.
  • To highlight its applications across various stages, from target identification to clinical use.

Main Methods:

  • Global gene expression profiling using microarrays.
  • Integration with gene knockout/knockdown techniques like RNA interference.
  • Analysis of basal/constitutive gene expression patterns.

Main Results:

  • Gene expression profiling aids in cancer classification and pathway elucidation.
  • It identifies potential therapeutic targets and predicts drug sensitivity/resistance.
  • Molecular signatures of drug action, including on-target and off-target effects, can be defined.

Conclusions:

  • Gene expression profiling is invaluable for cancer therapeutic discovery, development, and clinical application.
  • It facilitates biomarker identification for proof-of-concept, pharmacodynamics, and patient stratification.
  • This technology enhances the precision and efficacy of cancer treatments.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then processed and...